Hormone replacement therapy and the risk of breast cancer: How much should women worry about it?
Author:
Affiliation:
1. Winton Centre for Risk and Evidence Communication, University of Cambridge, Centre for Mathematical Sciences, Cambridge, UK
Publisher
SAGE Publications
Subject
Obstetrics and Gynecology
Link
http://journals.sagepub.com/doi/pdf/10.1177/2053369119898586
Reference4 articles.
1. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
2. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers
3. Communicating health risks in science publications: time for everyone to take responsibility
4. The Drug Facts Box: Improving the communication of prescription drug information
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A guide to Hormone Replacement Therapy (HRT);Independent Nurse;2022-12-02
2. Guide to Hormone replacement therapy (HRT);Practice Nursing;2022-03-01
3. Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk;Climacteric;2022-02-11
4. The menopause: symptoms, treatments and implications for women’s health and well-being;Primary Health Care;2022-02-09
5. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer;Breast Disease;2021-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3